

HY-170306 · 50 mg
MedChemExpress · Cat: HY-170306
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/lz9.html
Description
LZ9 is a ATP-competitive CDK1 and CDK2 inhibitor. LZ9 has the potential for the research of colorectal cancer CRC .





